Clinical Trials Directory

Trials / Completed

CompletedNCT06613776

Evaluation of the Effect of Antibiotic Prophylaxis (2g Amoxicillin One Hour Before Surgery) on an Inflammatory Factor (PGE2) in Salivary Samples After Third Molars Surgery

Evaluation of the Effect of Antibiotic Prophylaxis on Inflammatory Factor in Salivary Samples After Third Molars Surgery

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
18 (actual)
Sponsor
Universidad Católica San Antonio de Murcia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This clinical trial aims to evaluate the impact of antibiotics on inflammation and pain in patients who have undergone mandibular third molar surgery. The primary research questions are: 1. Do antibiotics reduce pain following third molar surgery? 2. Do antibiotics influence facial swelling and the patient\'s ability to open their mouth? 3. Do antibiotics affect the levels of a specific inflammatory marker in saliva post-surgery? Participants will be randomly assigned to receive either antibiotic capsules or placebo capsules. The study will include the following procedures: Medication: Participants will take four capsules (either antibiotics or placebo) as part of their standard surgical care. Saliva Samples: Saliva samples will be collected at three time points: before surgery, 24 hours after surgery, and 7 days post-surgery. Measurements: Facial swelling and mouth opening will be assessed by the investigator at each time point. By comparing the outcomes between the antibiotic and placebo groups, researchers aim to determine the effectiveness of antibiotics in managing post-surgical inflammation and pain.

Conditions

Interventions

TypeNameDescription
DRUGAmoxicillin4 capsules of amoxicillin 500mg, 2 grams in total, one hour before surgery
DRUGPlacebo4 empty capsules of amoxicillin 500mg (placebo), one hour before surgery

Timeline

Start date
2023-10-05
Primary completion
2024-05-27
Completion
2024-07-25
First posted
2024-09-26
Last updated
2024-09-26

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06613776. Inclusion in this directory is not an endorsement.